CHD
Church & Dwight Co., Inc.84.55
-0.46-0.54%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Reaffirms outlook, details execution.
Q&A largely reaffirmed Investor Day's 2026 outlook of 3%-4% organic growth, split as 3% U.S., 8% international, 5% SPD, with Q1 pressured by OxiClean's Costco loss. Divesting Vitamins stands out as a pivotal pivot, freeing crucial management mindshare from a private-label drag for ARM & HAMMER's acceleration beyond its 2.8% 25-year CAGR. Touchland's international hits expectations amid regulatory snags, but management stays picky on channels—no mass soon after positive club test. Brands trump promotions, set to normalize. Confident tone prevails; watch ARM & HAMMER momentum.
Key Stats
Market Cap
20.60BP/E (TTM)
26.67Basic EPS (TTM)
3.17Dividend Yield
0.01%Recent Filings
10-K
FY2025 results
Church & Dwight posted FY2025 net sales of $6.2B, up 1.6% y/y, with Consumer Domestic (77% of sales) growing 0.9% on Touchland acquisition gains offset by Flawless/Spinbrush/Waterpik showerhead exits and vitamin declines, while Consumer International rose 5.4% on volume. Q4 saw VMS divestiture charge of $58.5M but portfolio repositioning for faster growth; gross margin dipped to 44.7% from exit costs and tariffs, yet operating margin leaped to 17.4% absent prior VMS impairment. Diluted EPS hit $3.02, up 27%, with ops cash at $1.2B funding $900M buybacks. Strong cash conversion cycle shortened to 20 days. Q4 momentum built via power brands, but Waterpik trade name risks impairment from demand erosion. Intense competition threatens sales.
8-K
Q4 beat, VMS sold, 2026 outlook
Church & Dwight beat Q4 2025 outlooks with net sales up 3.9% to $1,644.2 million and adjusted EPS rising 11.7% to $0.86, while full-year organic sales grew 0.7% to $6,203.2 million despite VMS exit drag. Portfolio sharpened by closing VITAFUSION and L'IL CRITTERS sale on December 31, 2025, incurring $45.6 million after-tax charge; board hiked dividend 4.2% to $0.3075 quarterly. 2026 eyes 3-4% organic sales, 5-8% adjusted EPS growth. Exits unlock focus on faster lines.
8-K
Sells VMS brands to Piping Rock
Church & Dwight signed a definitive agreement on December 9, 2025, to sell its VitaFusion and L'il Critters brands—less than 5% of 2025 net sales—to Piping Rock Health Products, including Washington facilities. Close expected before year-end, subject to conditions. Deal triggers $40-45 million after-tax Q4 charge. Portfolio sharpens instantly.
8-K
Board drops tenure limits
Church & Dwight's Board on December 4, 2025, amended its Corporate Governance Guidelines to scrap tenure limits for directors, while keeping the age 75 retirement rule. This aligns with most S&P 500 peers, favoring case-by-case refreshment over rigid caps. Continuity trumps turnover. The change balances experience with renewal.
8-K
Q3 sales, EPS beat
Church & Dwight beat Q3 expectations with net sales up 5.0% to $1,585.6 million on 3.4% organic growth, fueled by volume gains across domestic, international, and specialty units. Adjusted EPS hit $0.81, topping the $0.72 outlook; cash from operations surged 19.6% to $435.5 million. Strong execution lifts full-year guidance: sales +1.5%, adjusted EPS ~$3.49, cash flow ~$1.2 billion. Momentum builds.
IPO
Website
Employees
Sector
Industry
CL
Colgate-Palmolive Company
78.95-0.48
CLX
Clorox Company (The)
99.82-1.90
DQWS
Dswiss Inc
0.04+0.00
EPC
Edgewell Personal Care Company
17.76+0.24
HNST
The Honest Company, Inc.
2.86+0.05
KMB
Kimberly-Clark Corporation
102.54-0.26
NWL
Newell Brands Inc.
3.77+0.00
PG
Procter & Gamble Company (The)
145.21+0.08
SPB
Spectrum Brands Holdings, Inc.
60.20-1.38
UL
Unilever PLC
64.33-0.71